| Financial Year |
March 31 2023 |
| Monetary Funds |
65,584,197.53 |
| Held-for-trading Financial Assets |
50,533,296.81 |
| Notes Receivable |
32,330,865.81 |
| Accounts Receivable |
40,367,198.89 |
| Advances to Suppliers |
6,478,086.44 |
| Other Receivables |
3,360,919.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
45,590,024.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,356,889.79 |
| Total Current Assets |
259,177,270.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
885,772.16 |
| Investment Properties |
114,447,141.55 |
| Fixed Assetes |
128,751,186.74 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,114,942.58 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,089,102.77 |
| Deferred Income Tax Assets |
25,319.46 |
| Other Non-Current Assets |
850,000.00 |
| Sub-Total of Non-Current Assets |
261,310,734.79 |
| Total Assets |
520,488,005.64 |
| Short-Term Loans |
10,015,155.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,240,375.76 |
| Accounts Payable |
36,875,983.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,109,474.52 |
| Taxes Payable |
8,686,552.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,330,735.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,599,636.37 |
| Other Current Liabilities |
22,477,162.85 |
| Sub-Total of Current Liabilities |
119,593,744.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,461,683.74 |
| Deferred Income Tax Liabilities |
25,319.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,878,414.35 |
| Total Liabilities |
134,472,159.27 |
| Paid-In Capital(Or Share Stock) |
120,000,000.00 |
| Capital Surplus |
204,801,929.89 |
| Surplus Reserve |
44,684,396.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
16,975,398.72 |
| Minority Stockholder's Interest |
-931,900.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
386,947,747.36 |
| Owner's Equity（Stockholder's Equity） |
386,015,846.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
520,488,005.64 |
